Sagimet Biosciences Series Stock Probability of Future Stock Price Finishing Over 43.33
| SGMT Stock | 4.39 0.15 3.30% |
Sagimet |
Sagimet Biosciences Target Price Odds to finish over 43.33
The tendency of Sagimet Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over 43.33 or more in 90 days |
| 4.39 | 90 days | 43.33 | close to zero percent |
Based on a normal probability distribution, the odds of Sagimet Biosciences to move over 43.33 or more in 90 days from now is close to zero percent (This Sagimet Biosciences Series probability density function shows the probability of Sagimet Stock to fall within a particular range of prices over 90 days) . Probability of Sagimet Biosciences price to stay between its current price of 4.39 and 43.33 at the end of the 90-day period is about 61.3 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.99 . This usually implies as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Sagimet Biosciences will likely underperform. Additionally Sagimet Biosciences Series has an alpha of 0.3873, implying that it can generate a 0.39 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Sagimet Biosciences Price Density |
| Price |
Predictive Modules for Sagimet Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sagimet Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sagimet Biosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Sagimet Biosciences is not an exception. The market had few large corrections towards the Sagimet Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Sagimet Biosciences Series, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Sagimet Biosciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.39 | |
β | Beta against Dow Jones | 1.99 | |
σ | Overall volatility | 1.01 | |
Ir | Information ratio | 0.08 |
Sagimet Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Sagimet Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Sagimet Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Sagimet Biosciences is way too risky over 90 days horizon | |
| Sagimet Biosciences appears to be risky and price may revert if volatility continues | |
| Sagimet Biosciences has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 2 M. Net Loss for the year was (27.88 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Sagimet Biosciences generates negative cash flow from operations | |
| Sagimet Biosciences has a frail financial position based on the latest SEC disclosures | |
| About 70.0% of the company shares are owned by institutional investors | |
| Latest headline from investing.com: Sagimet Biosciences SWOT analysis promising NASH drug faces funding hurdles |
Sagimet Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Sagimet Stock often depends not only on the future outlook of the current and potential Sagimet Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sagimet Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 10.5 M | |
| Cash And Short Term Investments | 94.9 M |
Sagimet Biosciences Technical Analysis
Sagimet Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Sagimet Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Sagimet Biosciences Series. In general, you should focus on analyzing Sagimet Stock price patterns and their correlations with different microeconomic environments and drivers.
Sagimet Biosciences Predictive Forecast Models
Sagimet Biosciences' time-series forecasting models is one of many Sagimet Biosciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Sagimet Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Sagimet Biosciences
Checking the ongoing alerts about Sagimet Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Sagimet Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Sagimet Biosciences is way too risky over 90 days horizon | |
| Sagimet Biosciences appears to be risky and price may revert if volatility continues | |
| Sagimet Biosciences has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 2 M. Net Loss for the year was (27.88 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Sagimet Biosciences generates negative cash flow from operations | |
| Sagimet Biosciences has a frail financial position based on the latest SEC disclosures | |
| About 70.0% of the company shares are owned by institutional investors | |
| Latest headline from investing.com: Sagimet Biosciences SWOT analysis promising NASH drug faces funding hurdles |
Additional Tools for Sagimet Stock Analysis
When running Sagimet Biosciences' price analysis, check to measure Sagimet Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sagimet Biosciences is operating at the current time. Most of Sagimet Biosciences' value examination focuses on studying past and present price action to predict the probability of Sagimet Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sagimet Biosciences' price. Additionally, you may evaluate how the addition of Sagimet Biosciences to your portfolios can decrease your overall portfolio volatility.